ArticleEcancermedicalscience2022
Fumarate hydratase-deficient renal cell carcinoma in extended remission with bevacizumab and erlotinib.
Shubham Tomar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it